Service
Two or more antidepressants didn’t work. That qualifies you for the one that was specifically designed to. Our Spravato treatment clinic in Powell TN provides the only FDA-approved nasal spray for treatment-resistant depression, and most insurance plans cover it.
The Only Nasal Spray Approved for Treatment-Resistant Depression — Now Within Easy Reach of Powell Residents
Powell has a way of taking care of its own. This close-knit community along the Emory Road corridor — anchored by generations of families, a proud high school tradition, and a deep connection to the surrounding Knox County landscape — understands that strength isn’t about pretending everything’s fine. Sometimes strength means acknowledging that what you’ve been doing isn’t working and finding something that will.
If you’ve tried two or more antidepressants and your depression hasn’t budged, conventional psychiatry calls that treatment-resistant depression. You probably just call it exhausting. Spravato was developed for exactly this scenario. It’s the first medication the FDA has ever approved specifically for adults whose depression has resisted standard treatment — and Revitalist is a fully REMS-certified provider, operating from our Knoxville clinic just a short drive from Powell down I-75 or Clinton Highway.
What Spravato treatment in Powell TN through Revitalist delivers:
The only FDA-approved nasal spray designed specifically for treatment-resistant depression
Insurance coverage available through most major carriers — we handle verification and prior authorization
Clinically demonstrated improvement within 24 hours of the first dose
Physician-supervised sessions in a private, comfortable treatment environment
A completely different biological mechanism from every antidepressant you've already tried
83% of our patients report significant improvement after completing their initial treatment series.
Spravato exists because traditional antidepressants fail roughly one in three people who take them. That’s not a controversial claim — it’s the clinical reality that drove Janssen Pharmaceuticals to develop esketamine nasal spray and the FDA to approve it through an accelerated review process.
What Sets Spravato Apart:
Built for Treatment Resistance: The FDA approved Spravato specifically for patients who haven't responded to two or more adequate antidepressant trials — not as a general-purpose antidepressant
Rapid Clinical Response: Phase 3 data showed statistically significant improvement within 24 hours, with remission rates nearly three times higher than placebo at four weeks
Insurance as Standard: FDA approval means most commercial and government insurance plans cover Spravato for qualifying patients, unlike off-label IV ketamine
Simple Administration: A self-administered nasal spray under medical supervision — no IV lines, no injections, no anesthesia
Proven Relapse Prevention: The SUSTAIN-1 trial demonstrated that continuing Spravato treatment significantly reduced the risk of depressive relapse in patients who had achieved remission
A pivotal study published in JAMA Psychiatry confirmed that patients who continued Spravato treatment after achieving remission experienced significantly lower relapse rates than those switched to placebo. Among patients in stable remission, those who stayed on esketamine maintained their gains at rates that far outperformed the control group — critical evidence that Spravato doesn’t just produce temporary relief but sustains it over time.
Speed of Relief
Spravato® Therapy
Hours to days
Traditional Antidepressants
Success Rate
Spravato® Therapy
Traditional Antidepressants
10-30% for treatment-resistant cases
Spravato® Therapy
Often covered for approved indications
Traditional Antidepressants
Generally covered but limited effectiveness
Mechanism of Action
Spravato® Therapy
Glutamate/NMDA system
Traditional Antidepressants
Serotonin/dopamine systems
Spravato® Therapy
Traditional Antidepressants
Daily self-administered pills
Spravato® Therapy
Traditional Antidepressants
Often persistent and ongoing
“I taught elementary school in Powell for nineteen years, and the last three were brutal. Depression made every morning feel like I was dragging myself through wet cement just to get to the classroom. My students deserved better, and I knew it. Two SSRIs and one SNRI later, nothing had shifted. When my psychiatrist told me I qualified for Spravato, I was nervous about trying something I’d never heard of. After my third session at the Spravato treatment clinic in Powell TN area, I caught myself laughing at a student’s joke — genuinely laughing, not performing it. That was the first crack in the wall.”
— Karen P., Powell, TN Patient
“Retirement was supposed to be the payoff for forty years of hard work. Instead, I sank into a depression I couldn’t climb out of. My wife and I had planned to fish Norris Lake every weekend, travel, enjoy the grandkids. None of that happened. I sat in a recliner and stared at the wall. My doctor ran me through two antidepressants over a year. Neither one touched it. He suggested the best Spravato treatment clinic in Powell, and my Medicare Advantage plan covered it. Four sessions in, I pulled the boat out of storage. Six sessions in, my wife said the man she married had come back.”
— Don W., Powell, TN Patient
“Anxiety and depression hit me during my senior year at Powell High, and they never really left. I’m thirty-one now, and I’ve been on medication since I was eighteen. Nothing worked long enough to matter. A coworker mentioned Spravato treatment in Powell TN through Revitalist, and honestly, I thought it sounded too good. But after my first session, something shifted. It wasn’t dramatic fireworks — it was quieter than that. The constant background noise in my head just got softer. By week three, I realized I hadn’t catastrophized about work in days. That had never happened before.”
— Tyler K., Powell, TN Patient
You’ve done your part — taken the medications, waited the weeks, followed the protocols. Spravato picks up where those treatments left off, using a mechanism they were never designed to reach.
Spravato holds specific FDA approvals, and our full treatment menu extends across the range of resistant mental health and pain conditions:
When two or more antidepressants haven’t provided adequate relief
Rapid intervention for patients with active suicidal thoughts
The medications you’ve already tried weren’t defective. They just targeted the wrong system for your particular brain chemistry. Understanding this distinction is the key to understanding why Spravato works.
Spravato’s active ingredient, esketamine, blocks NMDA receptors within the glutamate network. This blockade sets off a chain reaction your previous medications never triggered:
The S-enantiomer formulation in Spravato is approximately four times more potent at the NMDA receptor than the R-enantiomer, making it a more concentrated and targeted tool than racemic ketamine.
Traditional antidepressants — SSRIs, SNRIs, tricyclics, MAOIs — all revolve around monoamine neurotransmitters: serotonin, norepinephrine, dopamine. These chemical messengers influence mood, and adjusting their levels helps a majority of depression patients. But your brain isn’t a single-switch system. Depression can also stem from dysfunction in the glutamate network — a separate signaling system that governs how neurons communicate, form memories, adapt to new information, and repair themselves.
When glutamate signaling breaks down, the result looks a lot like what serotonin-based depression looks like from the outside: persistent low mood, cognitive fog, loss of interest, fatigue, and emotional numbness. But the internal mechanism is entirely different, which is why serotonin-focused medications don’t fix it.
One criticism of rapid-acting treatments is that the benefit might be temporary. The SUSTAIN-1 trial addressed this directly. Patients who achieved remission or stable response during initial Spravato treatment were randomized to continue esketamine or switch to placebo. The results were unambiguous: patients who stayed on Spravato relapsed at dramatically lower rates. This maintenance data is what convinced the FDA that Spravato isn’t a quick fix — it’s a sustainable treatment strategy.
The long-term SUSTAIN-3 extension study, tracking over 1,100 patients for up to 6.5 years, identified no new safety concerns during continued treatment. Depression improvements generally persisted among patients who maintained their regimen.
Treatment begins with a comprehensive consultation where our physicians review your medical history, psychiatric background, and the medications you’ve tried. We verify that you meet the clinical criteria for treatment-resistant depression — typically defined as an inadequate response to at least two antidepressants taken at proper doses for adequate durations.
During this visit, our team initiates insurance verification. We handle prior authorizations, document your treatment history for your carrier, and provide a clear picture of your expected costs before anything starts. Powell residents walk out knowing exactly where they stand.
Our Knoxville clinic on Flickenger Lane is a quick drive from Powell — south on I-75 or down Clinton Highway to I-640, then west. When you arrive, we take a pre-treatment blood pressure reading and do a brief check-in.
You’ll self-administer the Spravato nasal spray in a private treatment room, guided by our clinical staff. The spray itself takes about fifteen minutes. Each device delivers two sprays containing 28 mg of esketamine; your physician determines whether your session involves two or three devices based on your prescribed dose (56 mg or 84 mg).
Then you settle in for the two-hour observation period required by the REMS program. Our staff monitors vitals and checks on you at regular intervals. This isn’t dead time — patients tell us it’s often the most reflective, restorative part of their week. Bring headphones if you like music. Bring a journal if you like writing. Or just rest.
Spravato follows an FDA-structured protocol that phases from intensive to maintenance:
We coordinate directly with your Powell-area psychiatrist, therapist, or primary care physician. Spravato works most effectively as part of a broader treatment picture, and we ensure every provider involved in your care stays informed and aligned.
The FDA requires every facility administering Spravato to hold REMS certification. That means documented training, safety protocols, patient monitoring systems, and registry enrollment. Revitalist doesn't just meet those minimums — we've built our entire clinical operation around them. When you walk into the best Spravato treatment clinic in Powell, every detail is designed for your safety.
The prior authorization process can be a maze. Our dedicated team navigates it for you, documenting your treatment history, communicating with your carrier, and securing approvals before your first session. You'll know your coverage status and out-of-pocket costs upfront — no surprises.
Our physicians focus exclusively on treatment-resistant conditions. They've administered thousands of Spravato and IV ketamine treatments, refined their approach through direct clinical observation, and stay deeply engaged with emerging research. That concentration of experience produces better outcomes for every Powell patient who walks through our door.
Every Spravato visit includes a two-hour monitoring period. In a clinical space that feels cold or institutional, those hours feel long. In ours — private rooms, comfortable chairs, soft lighting, a warm and welcoming atmosphere — they feel restorative. The difference matters more than most clinics realize.
The City of Knoxville and surrounding Knox County communities like Powell have made mental health awareness a growing priority. Revitalist contributes by making advanced, FDA-approved treatment accessible close to home. When effective care exists but requires a two-hour drive to Nashville or a cross-country flight to a research hospital, it might as well not exist. We bring it here.
Some patients are best served by Spravato. Others by IV ketamine. Some benefit from both. Our clinic offers the full range: Spravato (Esketamine) — FDA-approved, insurance-covered nasal spray for TRD IV Ketamine Therapy — Direct intravenous delivery for treatment-resistant conditions including depression, PTSD, anxiety, and chronic pain Vitamin Infusion Therapy — Complementary support for brain health and overall recovery
Spravato® safety profile has been studied extensively through Phase 3 clinical trials involving thousands of patients, plus years of real-world use since its 2019 approval. The REMS program exists to ensure that every administration occurs under conditions designed to minimize risk.
These effects typically resolve within 1-2 hours after treatment ends. Our medical team provides continuous monitoring throughout your session and observation period to ensure your comfort and safety.
Spravato® therapy may not be appropriate for individuals with:
During your consultation, our medical team will thoroughly review your health history and current medications to determine if Spravato® therapy is safe and appropriate for you.
Many patients report noticeable improvements within hours or days of their first treatment. Unlike traditional antidepressants that can take 4-8 weeks to show effects, Spravato’s rapid action through the glutamate system often provides relief during the first treatment session.
The FDA-approved protocol includes twice-weekly treatments for the first month (induction phase), weekly treatments for the second month (maintenance phase), and then weekly or bi-weekly treatments based on your response (continuation phase). Your specific protocol will be customized based on your individual needs and response to treatment.
Yes, many major insurance plans cover Spravato for FDA-approved indications like treatment-resistant depression. Coverage typically requires prior authorization and documentation of previous treatment failures. Our team will verify your specific benefits and guide you through the approval process.
No, you cannot drive or operate machinery until the next day after receiving Spravato. You must arrange transportation home after each session. This is a mandatory safety requirement due to the medication’s effects on cognition and coordination.
Your first session will begin with final preparations and a review of the self-administration process. You’ll use the simple nasal spray device under our medical team’s supervision, then relax in our comfortable treatment room during the required 2-hour monitoring period. Our staff will ensure your comfort and safety throughout the entire process.
Spravato is FDA-approved specifically for treatment-resistant depression and is often covered by insurance, while ketamine infusions are used off-label for various conditions and typically aren’t covered. Spravato is self-administered as a convenient nasal spray, while ketamine requires IV infusion. Both contain the same active compound but in different formulations.
Yes, Spravato was specifically developed and FDA-approved for treatment-resistant depression. Clinical trials demonstrated significant effectiveness in patients who had failed to respond to multiple previous antidepressants. The unique glutamate mechanism offers hope when serotonin-based treatments haven’t provided relief.
No, Spravato is designed to be used alongside an oral antidepressant as combination therapy. You should continue your current medications unless specifically directed otherwise by your healthcare provider. Our medical team will review your medications and coordinate with your psychiatrist as needed.
Long-term studies show that continued Spravato treatment can provide sustained improvement in depression symptoms with manageable side effects. The SUSTAIN studies demonstrated that patients who responded to initial treatment could maintain their improvement with ongoing therapy. Regular monitoring ensures safe, effective long-term use.
Take the first step toward healing:
Free Assessment
Personalized treatment plan designed for your specific condition
Rapid relief often within hours of your first treatment
Insurance coverage verification and prior authorization support
Compassionate care from experienced mental health professionals
